Search Results 671-680 of 2038 for 搜索引擎平台开发咨询邮箱：lgooxc@hotmail.com

1. Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma - Mayo Clinic

   This pilot clinical trial studies how well buparlisib works in treating patients with non-Hodgkin lymphoma that has returned or does not respond to treatment.

2. Biospecimens analysis in healthy controls - Mayo Clinic

   The purpose of this study is to collect healthy patient samples and give us a normal patient levels of antibodies, cytokines and other meaningful biomarkers ...

3. Faculty - Department of Physiology and Biomedical Engineering - Mayo Clinic Research

   Faculty including scientists, engineers and physicians work together in the Department of Physiology and Biomedical Engineering at Mayo Clinic.

4. Faculty - Center for Individualized Medicine - Mayo Clinic Research

   Robinson, Steven I. M.B.B.S.. Robinson.Steven@mayo.edu; Associate Professor of Oncology. More about research at Mayo Clinic.

5. A Blood Collection Protocol to Study the Immune Responses of Cancer Patients with Malignancies - Mayo Clinic

   Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...

6. Phase 2 Study of Ipilimumab in Children and Adolescents (12 to < 18 Years) With Previously Treated or Untreated, Unresectable Stage III or Stage lV Malignant Melanoma - Mayo Clinic

   Phase 2 Study of Ipilimumab in Children and Adolescents (12 to < 18 Years) With Previously Treated or Untreated, Unresectable Stage III or Stage lV Malignant ...

7. Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

8. A Study to Evaluate MUC1 Vaccine to Prevent Lung Cancer in Current and Former Smokers at High Risk for Lung Cancer - Mayo Clinic

   The purpose of this study is to evaluate immunogenicity of the vaccine, assessed at week 12, based on the increase in IgG anti-MUC1 antibody titer over the pre- ...

9. Collaborators - Infectious Diseases Lab - Mayo Clinic Research

   Mayo Clinic's Infectious Diseases Laboratory, led by Robin Patel, M.D., collaborates with scientists and researchers on infectious diseases research.

10. Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors - Mayo Clinic

    About this study. Estrogen can cause the growth of breast cancer cells. Hormone therapy using tamoxifen citrate may fight breast cancer by blocking the use ...